Rajwanth Veluswamy, MD

Thomas Marron, MD, PhD, is Assistant Director of Immunotherapy and Early Phase Trials at The Tisch Cancer Institute and Assistant Professor of Medicine (Hematology and Medical Oncology) at the Icahn School of Medicine at Mount Sinai. As a member of the Center for Thoracic Oncology, Dr. Marron treats thoracic malignancies, including non-small cell lung cancer, small cell lung cancer, and malignant pleural mesothelioma. He leads numerous clinical trials for thoracic malignancies and hepatocellular carcinoma (liver cancer). He also leads the Phase 1 trials program at The Mount Sinai Hospital, where he enrolls patients into dozens of trials focused on development of novel cancer immunotherapies. As a member of The Tisch Cancer Institute and the Precision Immunology Institute, Dr. Marron works closely with basic scientists across the Mount Sinai Health System, translating preclinical findings into clinical advances. He leads a large translational neoadjuvant program focused on clinical trials for multiple types of cancer. The goal of these trials is to decrease the likelihood that cancer will return after surgery; in parallel, they support deep interrogation of the effect of new and standard therapies on the tumor immune microenvironment at the single-cell level. Further, the trials enable Dr. Marron and collaborators to define combination approaches that optimize response rates and the durability of novel immune-based therapies, while minimizing toxicity.

Located in the vibrant city of New York, NY, Ruttenberg Treatment Center stands as a pillar of healthcare excellence. Within its walls, a dedicated team works tirelessly to provide top-tier medical services to the local community and beyond. Boasting a strategic partnership with the esteemed Mount Sinai Health System, this center is committed to offering cutting-edge treatments and compassionate care to all who walk through its doors. At Ruttenberg Treatment Center, innovation and expertise converge to deliver unparalleled patient care. As part of the Mount Sinai Health System network, this facility upholds a legacy of medical excellence and a deep-rooted commitment to advancing healthcare standards. With a strong focus on research and education, Ruttenberg Treatment Center remains at the forefront of healthcare, continuously expanding its services to address the evolving needs of the community it serves. Generated using this brand's available information

Located in the vibrant city of New York, NY, Ana Acuna-Villaorduna, MD, is a distinguished healthcare facility known for its unwavering dedication to providing top-tier medical services. Situated within the Mount Sinai Health System, this establishment is part of an integrated network that spans various medical disciplines, from the Icahn School of Medicine at Mount Sinai to the Mount Sinai Phillips School of Nursing. With a commitment to excellence in patient care, research, and education, this facility plays a crucial role in meeting the diverse health needs of the local community. Boasting a comprehensive ambulatory network and multiple hospital campuses, Ana Acuna-Villaorduna, MD, is at the forefront of delivering exceptional healthcare services both locally and globally. Born from the merger of Mount Sinai Medical Center and Continuum Health Partners, this institution continues to uphold its reputation for providing outstanding medical care while adapting to evolving healthcare demands. Whether you seek specialized treatment or preventive care, this healthcare facility remains dedicated to serving patients with compassion and expertise. Generated using this brand's available information